Lactacyd Radiance (Lactic Acid) Prophetic Patch Test
- Registration Number
- NCT00679562
- Lead Sponsor
- Sanofi
- Brief Summary
Primay objective:
To evaluate the potential of the products in eliciting adverse skin reaction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Test area should have a healthy or normal skin
- Individuals free of any systemic or dermatological disorder which, in the opinion of the investigative personnel would interfere with the study results or increase the risk of adverse reaction
- Not currently use of steroid or any medication during the test
Exclusion Criteria
-
History of Allergy or Allergic Reaction to:
- Hey Fever
- Asthma
- Poison Ivy
- Food
- Cosmetics
- Soap
- Detergent
- Metal
- Jewelry
- Lather
- Fabric
- Medication
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 2 Distilled water - 1 Lactic Acid -
- Primary Outcome Measures
Name Time Method Reaction after patch removal. at 15-30 minutes and day 3
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of lactic acid in Lactacyd Radiance influence skin irritation responses?
How does Lactacyd Radiance compare to other topical hygiene agents in preventing adverse skin reactions?
Are there specific biomarkers that correlate with skin irritation risk in lactic acid-based formulations?
What are the potential adverse events associated with lactic acid use in skin care products and their management?
What other compounds or formulations are being studied by Sanofi for skin irritation prevention in hygiene contexts?
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇹🇭Bangkok, Thailand
Sanofi-Aventis Administrative Office🇹🇭Bangkok, Thailand